PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 33 filers reported holding PHARMACYTE BIOTECH INC in Q4 2023. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $14,473 | +89.1% | 7,384 | +128.7% | 0.00% | – |
| Q1 2024 | $7,653 | +89.0% | 3,229 | +72.2% | 0.00% | – |
| Q4 2023 | $4,050 | +58.3% | 1,875 | +53.9% | 0.00% | – |
| Q3 2023 | $2,558 | +255700.0% | 1,218 | +141.2% | 0.00% | – |
| Q1 2023 | $1 | 0.0% | 505 | +144.0% | 0.00% | – |
| Q4 2022 | $1 | – | 207 | +113.4% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 97 | -91.6% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 1,161 | +78.6% | 0.00% | – |
| Q4 2021 | $2,000 | -90.9% | 650 | -90.8% | 0.00% | -100.0% |
| Q3 2021 | $22,000 | – | 7,070 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,217,828 | $3,045,000 | 0.44% |
| Ayrton Capital LLC | 153,130 | $383,000 | 0.36% |
| Shay Capital LLC | 662,337 | $1,656,000 | 0.27% |
| EQUITEC PROPRIETARY MARKETS, LLC | 258,694 | $647,000 | 0.09% |
| Anson Funds Management LP | 193,400 | $484,000 | 0.05% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 44,944 | $112,000 | 0.00% |
| Jump Financial, LLC | 10,300 | $26,000 | 0.00% |
| Aspire Private Capital, LLC | 800 | $2,000 | 0.00% |
| Schonfeld Strategic Advisors LLC | 30,400 | $76,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 58 | $0 | 0.00% |